V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010478 | 190006356 | 1.61 | 95.5 | Palliative (P) | 2020-01-02 | 2020-02-05 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 100185268 |
| 190010480 | 190006357 | 1.66 | 82 | null | 2017-06-22 | 2017-08-24 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101828403 |
| 190010500 | 190006358 | 1.45 | 30.5 | Curative (C) | 2018-07-24 | 2018-09-18 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101662835 |
| 190010509 | 190006359 | 1.77 | 61.35 | Palliative (P) | 2018-01-14 | 2018-01-26 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100277654 |
| 190010510 | 190006360 | 0 | 8.4 | Palliative (P) | 2017-07-10 | 2018-01-27 | ECX | 02 | N | CAV | 101045967 |
| 190010523 | 190006361 | 1.57 | 11.4 | Neo-adjuvant (N) | 2016-02-19 | 2016-09-03 | FLUOROURACIL + OXALIPLATIN | 1 | Y | STS RHABDO RMS 2005 2ND TOPO CYCLO | 100632183 |
| 190010535 | 190006362 | 1.83 | 34.1 | Curative (C) | null | 2018-01-01 | Trial Unspecified | 02 | null | NOT MATCHED | 101646211 |
| 190010537 | 190006363 | 0 | 22 | Palliative (P) | 2017-12-25 | 2017-12-25 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101289076 |
| 190010540 | 190006364 | 1.73 | 84.55 | Curative (C) | 2020-07-25 | 2020-07-31 | ETOPOSIDE + IFOSFAMIDE | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101310410 |
| 190010544 | 190006365 | 1.63 | 55.5 | Curative (C) | 2017-12-23 | 2019-09-16 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100047691 |
| 190010549 | 190006366 | 1.68 | 99 | Adjuvant (A) | 2019-05-14 | 2019-06-10 | ETOPOSIDE + IFOSFAMIDE + MESNA | N | N | ETOPOSIDE + IFOSFAMIDE | 101624986 |
| 190010554 | 190006367 | 1.72 | 44.2 | Palliative (P) | 2018-12-25 | 2019-01-04 | LIPOSOMAL DOXORUBICIN | 02 | null | NOT MATCHED | 101448429 |
| 190010563 | 190006368 | 1.54 | 83.8 | Neo-adjuvant (N) | 2018-06-16 | 2018-06-24 | Irinotecan + Modified De Gramont | 02 | null | TRABECTEDIN | 101796420 |
| 190010571 | 190006369 | 1.58 | 50.05 | null | null | 2016-11-24 | OST Mifamurtide | 02 | N | CYCLOPHOSPHAMIDE | 101664435 |
| 190010578 | 190006370 | 0 | 52 | Curative (C) | 2015-01-12 | 2019-06-27 | VAI (Ifos 3g/m2) | 02 | N | IFOSFAMIDE | 101201115 |
| 190010589 | 190006371 | 1.68 | 59.6 | null | 2016-06-18 | 2016-11-16 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100945629 |
| 190010591 | 190006372 | 1.63 | 62.9 | Palliative (P) | 2017-06-21 | 2017-07-17 | EW EuroEwing 2012 Arm B IE | 01 | null | DOXORUBICIN + METHOTREXATE | 101084163 |
| 190010593 | 190006373 | 1.5 | 67.8 | null | 2020-07-30 | 2020-08-01 | Cetuximab + Radiotherapy Maint | 02 | N | CISPLATIN + DOXORUBICIN | 101788187 |
| 190010596 | 190006374 | 1.79 | 40 | null | 2018-06-09 | 2018-06-13 | DOXORUBICIN | null | null | DOXORUBICIN | 100167309 |
| 190010597 | 190006375 | 1.66 | 69 | Curative (C) | 2017-09-19 | 2018-02-08 | EW EuroEwing 2012 Arm B IE | 01 | N | EW EUROEWING 2012 ARM B IE | 100364039 |
| 190010598 | 190006376 | 1.51 | 60 | Curative (C) | 2018-03-09 | 2018-03-11 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101068976 |
| 190010604 | 190006377 | 1.63 | 68.5 | Neo-adjuvant (N) | 2017-08-04 | 2017-08-05 | DHAP | 02 | N | NOT MATCHED | 101695167 |
| 190010609 | 190006378 | 0 | 42.6 | null | 2017-11-20 | 2018-01-17 | Docetaxel | 02 | Y | EURAMOS TRIAL | 100533029 |
| 190010613 | 190006379 | 0 | 24 | null | 2016-10-24 | 2016-10-26 | EURO-EWING | 02 | Y | TRIAL | 100470668 |
| 190010618 | 190006380 | 0 | 31.4 | null | 2019-05-28 | 2019-09-23 | ETOPOSIDE | Y | N | EW EUROEWING 2012 ARM B VDC | 100180550 |
| 190010621 | 190006381 | 1.58 | 59.8 | null | 2016-08-26 | 2016-08-26 | NIVOLUMAB | 02 | null | EURAMOS TRIAL | 100869513 |
| 190010631 | 190006382 | 1.57 | null | 03 | 2017-07-08 | 2017-07-08 | EW EuroEwing 2012 Arm A VAI | 02 | N | CYCLOPHOSPHAMIDE | 101376355 |
| 190010643 | 190006383 | 0 | 37.4 | Curative (C) | 2021-04-19 | 2021-04-19 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100166300 |
| 190010645 | 190006384 | 1.79 | 68.9 | 03 | 2021-12-09 | 2021-12-31 | Doxorubicin 75mg/m2 | 01 | N | DOXORUBICIN | 101482072 |
| 190010650 | 190006385 | 1.83 | 79.2 | Adjuvant (A) | 2018-03-28 | 2018-03-28 | NIVOLUMAB | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100561190 |
| 190010658 | 190006387 | 0 | 48.8 | null | 2020-05-12 | 2020-05-20 | CARBOPLATIN | 02 | null | METHOTREXATE HIGH DOSE | 101606315 |
| 190010666 | 190006388 | 0 | 49.8 | null | null | 2017-05-09 | DOCETAXEL + GEMCITABINE | null | null | DOCETAXEL + GEMCITABINE | 100673802 |
| 190010672 | 190006389 | 0 | 62.5 | null | 2017-04-09 | 2017-04-16 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100847315 |
| 190010677 | 190006390 | 1.75 | 56.4 | Neo-adjuvant (N) | 2019-03-13 | 2019-03-31 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101071807 |
| 190010681 | 190006391 | 1.81 | 63.75 | Curative (C) | null | 2014-10-25 | EOX | null | null | EW EUROEWING 2012 ARM A VAI | 101015225 |
| 190010685 | 190006392 | 1.68 | 92 | Palliative (P) | 2017-02-24 | 2017-03-24 | Etoposide + Ifosfamide (3 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101159852 |
| 190010688 | 190006393 | 0 | 54 | Palliative (P) | 2019-09-04 | 2019-09-10 | Capecitabine | 02 | null | ETOPOSIDE | 100330018 |
| 190010689 | 190006394 | 1.68 | 62 | Palliative (P) | 2016-12-29 | 2017-01-22 | EW EuroEwing 2012 Arm A VAI | 02 | N | NOT MATCHED | 101803600 |
| 190010706 | 190006395 | 1.78 | 47 | Palliative (P) | 2017-03-09 | 2017-03-12 | Trial Unspecified | N | Y | DOXORUBICIN + IFOSFAMIDE | 101746046 |
| 190010707 | 190006396 | 1.56 | 89.8 | Curative (C) | 2019-11-13 | 2020-01-09 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 101496429 |
| 190010715 | 190006398 | 1.59 | 66 | null | 2019-05-28 | 2019-12-09 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 101401096 |
| 190010716 | 190006399 | 1.74 | 89.1 | null | 2017-07-13 | 2017-08-15 | OST Euramos 1 Closed Trial - AP | null | null | CISPLATIN + CYTARABINE | 100551431 |
| 190010719 | 190006400 | 0 | 52.2 | Curative (C) | 2018-09-08 | 2018-09-08 | OST Euramos 1 Closed Trial - M | 01 | N | OST M | 100144097 |
| 190010729 | 190006401 | 0 | 40 | Adjuvant (A) | 2017-03-31 | 2017-04-25 | Etoposide + Ifosfamide (3 days) | 02 | null | ETOPOSIDE + IFOSFAMIDE | 100411559 |
| 190010736 | 190006402 | 1.69 | 89.4 | Curative (C) | 2020-02-06 | 2020-05-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100400244 |
| 190010739 | 190006403 | 1.51 | 67 | Curative (C) | 2017-07-20 | 2018-02-04 | EW EuroEwing 2012 Arm A VAI | 02 | null | MAP | 100569513 |
| 190010741 | 190006404 | null | 69.8 | Palliative (P) | 2018-05-22 | 2018-11-04 | ETOPOSIDE + IFOSFAMIDE + MESNA | 02 | null | ETOPOSIDE + IFOSFAMIDE | 100422291 |
| 190010749 | 190006405 | 1.69 | 58 | Palliative (P) | 2018-08-15 | 2018-09-07 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100967392 |
| 190010755 | 190006406 | 1.52 | 52.1 | Palliative (P) | 2017-02-25 | 2017-02-25 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101847115 |
| 190010776 | 190006407 | 1.85 | 60.6 | Curative (C) | 2017-06-28 | 2017-06-30 | CISPLATIN + DOXORUBICIN + METHOTREXATE | 01 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101547765 |